Get an alert when CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-10-10 (in 5mo)

Last made up 2025-09-26

Watchouts

1 item

Cash

£190K

Latest balance sheet

Net assets

£528K

Equity attributable

Employees

11

Average over period

Profit before tax

-£2M

Period ending 2024-12-31

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £108,300
Operating profit -£3,446,700-£3,066,000
Profit before tax -£3,684,600-£2,345,000
Net profit -£3,690,700-£2,347,000
Cash £290,300£189,800
Total assets less current liabilities £4,610,100£4,646,600
Net assets -£153,200£528,000
Equity -£153,200£528,000
Average employees 1211
Wages £1,419,300£1,373,600
Directors' remuneration £514,300£508,100

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Year-on-year comparison hidden: this filing's period length differs materially from the prior year.

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Return on capital employed -74.8%-66.0%
Gearing (liabilities / total assets) 102.8%90.4%
Current ratio 0.70x0.65x
Interest cover -14.49x

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

Name history

Renamed 1 time since incorporation

  1. CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED 2014-11-26 → present
  2. CLINETIK LIMITED 2014-09-26 → 2014-11-26

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Consolidated group
Auditor
Frazier & Deeter (UK Audit) LLP
Audit opinion
Unqualified (clean)
Going concern
Material uncertainty disclosed

“In view of the above, the directors have concluded that a material uncertainty exists that may cast significant doubt upon the group's ability to continue as a going concern. Nevertheless, after making enquiries, and considering the uncertainties described above, the directors have concluded that it is appropriate to continue to adopt the going concern basis in preparing the financial statements.”

Group structure

  1. CAMBRIDGE MEDICAL TECHNOLOGIES LIMITED · parent
    1. Cambridge Medical Technologies, LLC 100% · United States · Medical device development
    2. Clinitech, LLC 100% · United States · Medical device development
    3. CMT Japan Inc 100% · Japan · Medical device development
    4. Clinitech Holdings Limited 100% · United Kingdom · Dormant
    5. Clinitech Limited 100% · United Kingdom · Dormant

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 2 resigned

Name Role Appointed Born Nationality
COOKE, James Director 2016-05-23 Jan 1966 British
JACHMANN, Emil Director 2014-09-26 Mar 1947 American
LACEY-SOLYMAR, Michael Julian Director 2015-10-16 Feb 1963 British
PRESS, Richard Director 2025-09-17 Jan 1939 American
Show 2 resigned officers
Name Role Appointed Resigned
CORNELIUS, James Director 2017-02-02 2025-11-11
DIBDEN, Lindsay George Director 2017-02-02 2019-02-13

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Mr Emil Frederick Jachmann Individual Shares 25–50% 2016-04-06 Active

Filing timeline

Last 20 of 101 total filings

Date Type Category Description
2026-03-23 SH01 capital Capital allotment shares PDF
2026-03-23 SH01 capital Capital allotment shares PDF
2026-03-23 SH01 capital Capital allotment shares PDF
2025-11-23 SH01 capital Capital allotment shares PDF
2025-11-14 TM01 officers Termination director company with name termination date PDF
2025-10-22 SH01 capital Capital allotment shares PDF
2025-10-21 SH01 capital Capital allotment shares PDF
2025-09-26 CS01 confirmation-statement Confirmation statement with updates PDF
2025-09-26 AA accounts Accounts with accounts type group
2025-09-25 AP01 officers Appoint person director company with name date PDF
2025-09-06 SH01 capital Capital allotment shares PDF
2025-09-06 SH01 capital Capital allotment shares PDF
2025-08-03 SH01 capital Capital allotment shares PDF
2025-08-03 SH01 capital Capital allotment shares PDF
2025-05-27 SH01 capital Capital allotment shares PDF
2024-11-21 SH01 capital Capital allotment shares PDF
2024-10-07 CS01 confirmation-statement Confirmation statement with updates PDF
2024-10-01 AA accounts Accounts with accounts type group
2024-08-06 SH01 capital Capital allotment shares PDF
2024-06-26 SH01 capital Capital allotment shares PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
15

last 12 months

Capital events
14

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page